{"id":2488,"date":"2021-01-12T00:39:47","date_gmt":"2021-01-12T00:39:47","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2488"},"modified":"2023-08-29T17:48:08","modified_gmt":"2023-08-29T17:48:08","slug":"fda-approval-acrux-launch-generic-testosterone-topical-solution-us","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2488","title":{"rendered":"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def"},"content":{"rendered":"<p><a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=ACR&amp;lang=cn\">\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)<\/a>\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002<\/p>\n<p>\u5916\u7528\u836f\u7269\u662f\u57fa\u4e8ePerrigo\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\uff0c\u5176\u5242\u91cf\u4e3a\u6bcf1.5\u6beb\u534730mg\u3002<\/p>\n<p>Acrux\u6700\u521d\u4e8e2018\u5e748\u6708\u5411FDA\u63d0\u4ea4\u4e86\u4e00\u4efd\u7b80\u77ed\u7684\u65b0\u836f\u7533\u8bf7\uff0c\u4ee5\u63a8\u5e7f\u5176\u777e\u916e\u4eff\u5236\u836f\u3002<\/p>\n<p>\u636e\u62a5\u9053\uff0c\u4eca\u5929FDA\u6279\u51c6\u4e86Acrux\u5728\u7f8e\u56fd\u7684\u4eff\u5236\u836f\u751f\u4ea7\u548c\u9500\u552e\u3002<\/p>\n<p>Acrux\u8463\u4e8b\u603b\u7ecf\u7406Michael Kotsanis\u8868\u793a\uff0cFDA\u7684\u6279\u51c6\u5bf9\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u4e2a\u201c\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u201d\u3002<\/p>\n<p>\u201c\u8fd9\u662f\u5bf9\u4ea7\u54c1\u5f00\u53d1\u548c\u76d1\u7ba1\u56e2\u961f\u52aa\u529b\u5de5\u4f5c\u548c\u5949\u732e\u7cbe\u795e\u7684\u8bc1\u660e\uff0c\u201d\u4ed6\u8865\u5145\u8bf4\u3002<\/p>\n<p>\u777e\u916e\u6eb6\u6db2\u5df2\u7ecf\u57286\u4e2a\u56fd\u5bb6\u9500\u552e\u3002<\/p>\n<h2>Dash Pharmaceuticals\u5c06\u5728\u7f8e\u56fd\u5546\u4e1a\u5316\u777e\u916e\u836f\u7269<\/h2>\n<p>\u4e3a\u4e86\u51c6\u5907\u597d\u83b7\u5f97\u6279\u51c6\uff0cAcrux\u53bb\u5e7410\u6708\u4e0eDash Pharmaceuticals\u7b7e\u7f72\u4e86\u4e00\u9879\u6392\u4ed6\u534f\u8bae\u3002<\/p>\n<p>\u6839\u636e\u534f\u8bae\uff0cDash\u8d1f\u8d23\u777e\u916e\u4ea7\u54c1\u5728\u7f8e\u56fd\u7684\u5546\u4e1a\u5316\uff0c\u5305\u62ec\u751f\u4ea7\u3001\u8425\u9500\u548c\u5206\u9500\u3002<\/p>\n<p>\u9500\u552e\u5229\u6da6\u5c06\u7531Dash\u548cAcrux\u5206\u4eab\u3002<\/p>\n<p>Kotsanis\u8868\u793a:\u201c\u6211\u4eec\u5f88\u9ad8\u5174\u80fd\u4e0eDash\u5408\u4f5c\uff0c\u5728\u672c\u8d22\u5e74\u5c06\u8fd9\u6b3e\u4ea7\u54c1\u63a8\u5411\u5e02\u573a\u3002\u201d<\/p>\n<h2>\u8d44\u91d1\u5145\u8db3\uff0c\u53ef\u4ee5\u5b9e\u65bd\u589e\u957f\u8ba1\u5212<\/h2>\n<p>\u53bb\u5e74\u5e74\u5e95\uff0cAcrux\u901a\u8fc7\u201c\u5f3a\u529b\u652f\u6301\u201d\u7684\u914d\u80a1\u878d\u8d44780\u4e07\u6fb3\u5143\uff0c\u5e76\u5c06\u901a\u8fc7\u80a1\u7968\u8d2d\u4e70\u8ba1\u5212\u518d\u878d\u8d44200\u4e07\u6fb3\u5143\u3002<\/p>\n<p>\u4e00\u4e2a\u65b0\u7684\u6218\u7565\u6295\u8d44\u8005BioScience Managers Translation Fund I\u8ba4\u8d2d\u4e86500\u4e07\u6fb3\u5143\u7684Acrux\u80a1\u4efd\uff0c\u83b7\u5f97\u4e8610%\u7684\u80a1\u4efd\u3002<\/p>\n<p>Kotsanis\u8868\u793a:\u201c\u5bf9\u690d\u5165\u7684\u9700\u6c42\u662f\u5bf9\u8be5\u516c\u53f8\u589e\u957f\u6218\u7565\u7684\u8ba4\u53ef\uff0c\u4e5f\u662f\u5bf9\u5176\u70ed\u95e8\u4eff\u5236\u836f\u7ba1\u9053\u7684\u6301\u7eed\u91cd\u5927\u8fdb\u5c55\u7684\u8ba4\u53ef\u3002\u201d<\/p>\n<p>Acrux\u76ee\u524d\u670913\u79cd\u975e\u4e13\u5229\u836f\u7269\u6b63\u5728\u7814\u53d1\u4e2d\uff0c\u5176\u4e2d3\u79cd\u5df2\u63d0\u4ea4FDA\u7533\u8bf7\u3002<\/p>\n<p>\u9664\u4e86\u777e\u916e\u6eb6\u6db2\uff0cAcrux\u8fd8\u5c06\u4e00\u79cd\u96cc\u6027\u6fc0\u7d20\u55b7\u96fe\u5242\u5546\u4e1a\u5316\uff0c\u572837\u4e2a\u56fd\u5bb6\u4ee5Lenzetto\u7684\u540d\u5b57\u9500\u552e\uff0c\u5728\u7f8e\u56fd\u4ee5Evamist\u7684\u540d\u5b57\u9500\u552e\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002 \u5916\u7528\u836f\u7269\u662f\u57fa\u4e8ePerrigo\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\uff0c\u5176\u5242\u91cf\u4e3a\u6bcf1.5\u6beb\u534730mg\u3002 Acrux\u6700\u521d\u4e8e2018\u5e748\u6708\u5411FDA\u63d0\u4ea4\u4e86\u4e00\u4efd\u7b80\u77ed\u7684\u65b0\u836f\u7533\u8bf7\uff0c\u4ee5\u63a8\u5e7f\u5176\u777e\u916e\u4eff\u5236\u836f\u3002 \u636e\u62a5\u9053\uff0c\u4eca\u5929FDA\u6279\u51c6\u4e86Acrux\u5728\u7f8e\u56fd\u7684\u4eff\u5236\u836f\u751f\u4ea7\u548c\u9500\u552e\u3002 Acrux\u8463\u4e8b\u603b\u7ecf\u7406Michael Kotsanis\u8868\u793a\uff0cFDA\u7684\u6279\u51c6\u5bf9\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u4e2a\u201c\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u201d\u3002 \u201c\u8fd9\u662f\u5bf9\u4ea7\u54c1\u5f00\u53d1\u548c\u76d1\u7ba1\u56e2\u961f\u52aa\u529b\u5de5\u4f5c\u548c\u5949\u732e\u7cbe\u795e\u7684\u8bc1\u660e\uff0c\u201d\u4ed6\u8865\u5145\u8bf4\u3002 \u777e\u916e\u6eb6\u6db2\u5df2\u7ecf\u57286\u4e2a\u56fd\u5bb6\u9500\u552e\u3002 Dash Pharmaceuticals\u5c06\u5728\u7f8e\u56fd\u5546\u4e1a\u5316\u777e\u916e\u836f\u7269 \u4e3a\u4e86\u51c6\u5907\u597d\u83b7\u5f97\u6279\u51c6\uff0cAcrux\u53bb\u5e7410\u6708\u4e0eDash Pharmaceuticals\u7b7e\u7f72\u4e86\u4e00\u9879\u6392\u4ed6\u534f\u8bae\u3002 \u6839\u636e\u534f\u8bae\uff0cDash\u8d1f\u8d23\u777e\u916e\u4ea7\u54c1\u5728\u7f8e\u56fd\u7684\u5546\u4e1a\u5316\uff0c\u5305\u62ec\u751f\u4ea7\u3001\u8425\u9500\u548c\u5206\u9500\u3002 \u9500\u552e\u5229\u6da6\u5c06\u7531Dash\u548cAcrux\u5206\u4eab\u3002 Kotsanis\u8868\u793a:\u201c\u6211\u4eec\u5f88\u9ad8\u5174\u80fd\u4e0eDash\u5408\u4f5c\uff0c\u5728\u672c\u8d22\u5e74\u5c06\u8fd9\u6b3e\u4ea7\u54c1\u63a8\u5411\u5e02\u573a\u3002\u201d \u8d44\u91d1\u5145\u8db3\uff0c\u53ef\u4ee5\u5b9e\u65bd\u589e\u957f\u8ba1\u5212 \u53bb\u5e74\u5e74\u5e95\uff0cAcrux\u901a\u8fc7\u201c\u5f3a\u529b\u652f\u6301\u201d\u7684\u914d\u80a1\u878d\u8d44780\u4e07\u6fb3\u5143\uff0c\u5e76\u5c06\u901a\u8fc7\u80a1\u7968\u8d2d\u4e70\u8ba1\u5212\u518d\u878d\u8d44200\u4e07\u6fb3\u5143\u3002 \u4e00\u4e2a\u65b0\u7684\u6218\u7565\u6295\u8d44\u8005BioScience Managers Translation Fund I\u8ba4\u8d2d\u4e86500\u4e07\u6fb3\u5143\u7684Acrux\u80a1\u4efd\uff0c\u83b7\u5f97\u4e8610%\u7684\u80a1\u4efd\u3002 Kotsanis\u8868\u793a:\u201c\u5bf9\u690d\u5165\u7684\u9700\u6c42\u662f\u5bf9\u8be5\u516c\u53f8\u589e\u957f\u6218\u7565\u7684\u8ba4\u53ef\uff0c\u4e5f\u662f\u5bf9\u5176\u70ed\u95e8\u4eff\u5236\u836f\u7ba1\u9053\u7684\u6301\u7eed\u91cd\u5927\u8fdb\u5c55\u7684\u8ba4\u53ef\u3002\u201d Acrux\u76ee\u524d\u670913\u79cd\u975e\u4e13\u5229\u836f\u7269\u6b63\u5728\u7814\u53d1\u4e2d\uff0c\u5176\u4e2d3\u79cd\u5df2\u63d0\u4ea4FDA\u7533\u8bf7\u3002 \u9664\u4e86\u777e\u916e\u6eb6\u6db2\uff0cAcrux\u8fd8\u5c06\u4e00\u79cd\u96cc\u6027\u6fc0\u7d20\u55b7\u96fe\u5242\u5546\u4e1a\u5316\uff0c\u572837\u4e2a\u56fd\u5bb6\u4ee5Lenzetto\u7684\u540d\u5b57\u9500\u552e\uff0c\u5728\u7f8e\u56fd\u4ee5Evamist\u7684\u540d\u5b57\u9500\u552e\u3002<\/p>\n","protected":false},"author":3,"featured_media":10471,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[726],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def<\/title>\n<meta name=\"description\" content=\"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def\" \/>\n<meta property=\"og:description\" content=\"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-12T00:39:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:48:08+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Acrux-Dash-Pharmaceuticals-testosterone-ASX-ACR-FDA.jpg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def\" \/>\n<meta name=\"twitter:description\" content=\"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Acrux-Dash-Pharmaceuticals-testosterone-ASX-ACR-FDA.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/\",\"name\":\"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-01-12T00:39:47+00:00\",\"dateModified\":\"2023-08-29T17:48:08+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def","description":"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def","og_description":"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/","og_site_name":"smallcapsCN","article_published_time":"2021-01-12T00:39:47+00:00","article_modified_time":"2023-08-29T17:48:08+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Acrux-Dash-Pharmaceuticals-testosterone-ASX-ACR-FDA.jpg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def","twitter_description":"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Acrux-Dash-Pharmaceuticals-testosterone-ASX-ACR-FDA.jpg","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/","url":"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/","name":"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-01-12T00:39:47+00:00","dateModified":"2023-08-29T17:48:08+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u5236\u836f\u516c\u53f8Acrux (ASX: ACR)\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u5176\u975e\u4e13\u5229\u777e\u916e\u5916\u7528\u6eb6\u6db2\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/fda-approval-acrux-launch-generic-testosterone-topical-solution-us\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"FDA\u7684\u6279\u51c6\u4e3aAcrux\u5728\u7f8e\u56fd\u63a8\u51fa\u975e\u4e13\u5229\u7684\u777e\u916e\u5916\u7528\u6eb6\u6db2\u94fa\u5e73\u4e86\u9053\u8def"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2488"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2488"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2488\/revisions"}],"predecessor-version":[{"id":10470,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2488\/revisions\/10470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10471"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}